WEIN MATTHEW (See Remarks) sold 1.0% of their position (199.00 shares) of METAGENOMI THERAPEUTICS, INC. on the open market
Open‑market sale worth $360.19 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/1/2025ACC: 0001193125-25-304177
Officer· See Remarks
Since Mar 2026
+95.80K
Net shares
Net buyer
$360.19
Total sold
1
Open market trades
0B · 1S
2
Total transactions
96K acquired · 199.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−199.00
Price / share
$1.81
Trade value
$360.19
% of position
1.0%
9/5/2025
19.43K→19.23K
Common Stock
Direct
Shares
+96K
Price / share
$1.60
Trade value
$153.60K
% of position
499.2%
12/1/2025
19.23K→115.23K
Total
Net shares
+95.80K
Net value
$153.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/5/2025 | S · Sale | −199.00 | $1.81 | $360.19 | 1.0% | 19.43K | 19.23K |
| Common Stock Direct | 12/1/2025 | A · Award | +96K | $1.60 | $153.60K | 499.2% | 19.23K | 115.23K |
| Total | +95.80K | $153.24K | ||||||
Derivative Transactions0
No derivative transactions reported